DAAs

DRUG5 trials

Sponsors

Egyptian Liver Hospital, Third Affiliated Hospital, Sun Yat-Sen University, Assiut University, Beijing Ditan Hospital

Conditions

Antiviral DrugChronic Hepatitis CHCC in Chronic HCV Patients With Advanced Liver FibrosisHepatitis C, Chronic

Phase 4

Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages

CompletedNCT04177043

Egyptian Liver HospitalHepatitis C, Chronic

Start: 2015-06-30End: 2018-12-31Updated: 2019-11-26

Unknown Phase

Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

CompletedNCT03884062

Egyptian Liver HospitalHCC in Chronic HCV Patients With Advanced Liver Fibrosis

Start: 2015-06-01End: 2019-01-01Updated: 2020-03-10

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

Third Affiliated Hospital, Sun Yat-Sen UniversityChronic Hepatitis C

Start: 2019-03-30End: 2019-09-30Target: 180Updated: 2019-03-25

Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital

Assiut UniversityAntiviral Drug

Start: 2019-06-01End: 2020-07-31Target: 80Updated: 2019-05-29

Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis C

Beijing Ditan HospitalChronic Hepatitis C

Start: 2019-08-01End: 2020-08-01Target: 1000Updated: 2019-08-28